SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.18-5.1%Dec 12 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (15924)8/3/2002 10:43:09 AM
From: Arthur Radley  Read Replies (1) of 17367
 
OT:
I noticed you suggested XOMA on the VD board, so I thought I would suggest another biotech for you to consider. I've had my fill of promising Phase II drugs and companies with no cash to see them through to launch, so with that said you might look at Allos(ALTH). First of all they are in a Phase III trial and they have well over $50M sitting in the bank. Their drug is on fast track approval and data so far has been nothing but positive. And the drug addresses a huge market.
Best of all, in this horrible biotech market, (ALTH) is showing strength on Wall Street. The current price is only a few pennies under their 52 week high. If one looks at the TA on the stock, you will find accumulation going on, institutional buying, insiders buying. Investor's Business Daily has an (A) ranking and RS of 96(Only a handfull of NASDAQ or NYSE stocks have such a high ranking by IBD.

Good luck with XOMA...for sure you have given it a chance to finally perform...and sometimes...miracles do happen!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext